Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Famotidine

×

Overview

What is Famotidine?

The active ingredient in famotidine for oral suspension is a histamine H-receptor antagonist. Famotidine is N-(aminosulfonyl)-3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide. The molecular formula of famotidine is CHNOS and its molecular weight is 337.43. Its structural formula is:



What does Famotidine look like?



What are the available doses of Famotidine?

Sorry No records found.

What should I talk to my health care provider before I take Famotidine?

Sorry No records found

How should I use Famotidine?

Famotidine for oral suspension is indicated in:

1. Short-term treatment of active duodenal ulcer. Most adult patients heal within 4 weeks; there is rarely reason to use famotidine at full dosage for longer than 6 to 8 weeks. Studies have not assessed the safety of famotidine in uncomplicated  active duodenal ulcer for periods of more than eight weeks.

2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer. Controlled studies in adults have not extended beyond one year.

3. Short-term treatment of active benign gastric ulcer. Most adult patients heal within 6 weeks. Studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks.

4. Short-term treatment of gastroesophageal reflux disease (GERD). Famotidine for oral suspension is indicated for short-term treatment of patients with symptoms of GERD (see , ).    Famotidine for oral suspension is also indicated for the short-term treatment of esophagitis due to GERD including erosive or ulcerative disease diagnosed by endoscopy (see , ).

5. Treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine adenomas) (see , ).

Duodenal Ulcer

Acute Therapy:

Maintenance Therapy:

Benign Gastric Ulcer

Acute Therapy:

Gastroesophageal Reflux Disease (GERD)

Clinical Studies

Dosage for Pediatric Patients less than 1 year of age Gastroesophageal Reflux Disease (GERD)

Pediatric Patients less than 1 year of age

Pediatric Patients less than 1 year of age

Gastroesophageal Reflux Disease (GERD)

Dosage for Pediatric Patients 1 to 16 years of age

Pediatric Patients 1 to 16 years of age

Pediatric Patients 1 to 16 years of age

Peptic ulcer

Gastroesophageal Reflux Disease with or without esophagitis including erosions and ulcerations

Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome, Multiple Endocrine Adenomas)

Oral Suspension

Directions for Preparing Famotidine for Oral Suspension

Stability of Famotidine for Oral Suspension

Concomitant Use of Antacids

Dosage Adjustment for Patients with Moderate or Severe Renal Insufficiency

CLINICAL PHARMACOLOGY IN ADULTS

PRECAUTIONS

PRECAUTIONS

PRECAUTIONS

PRECAUTIONS


What interacts with Famotidine?

Sorry No Records found


What are the warnings of Famotidine?

Sorry No Records found


What are the precautions of Famotidine?

Sorry No Records found


What are the side effects of Famotidine?

Sorry No records found


What should I look out for while using Famotidine?


What might happen if I take too much Famotidine?

ADVERSE REACTIONS

50

50


How should I store and handle Famotidine?

Store at 20°-25°C (68°-77°F) (see USP Controlled Room Temperature). PROTECT FROM LIGHT. KEEP TIGHTLY CLOSED. Sarafem is a registered trademark of Eli Lilly and Company. Propafenone HCl tablets are supplied as white, scored, round, film-coated tablets. 150 mg tablets embossed "5124" and "V" available in blisterpackss of 30.Propafenone HCl tablets are supplied as white, scored, round, film-coated tablets. 150 mg tablets embossed "5124" and "V" available in blisterpackss of 30.


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Pharmacokinetics

Non-Clinical Toxicology
General

Patients with Moderate or Severe Renal Insufficiency

Information for Patients

Drug Interactions

in vitro

Carcinogenesis, Mutagenesis, Impairment of Fertility

Salmonella typhimurium

Escherichia coli

in vivo

Pregnancy

Pregnancy Category B

Nursing Mothers

Pediatric Patients less than 1 year of age

Pharmacokinetics and Pharmacodynamics

Pediatric Patients

Pediatric Patients 1 to 16 years of age

Peptic ulcer

Gastroesophageal Reflux Disease with or without esophagitis including erosions and ulcerations

Geriatric Use

Pharmacokinetics

Patients with Moderate or Severe Renal Insufficiency

Dosage Adjustment for Patients with Moderate or Severe Renal Insufficiency

CLINICAL PHARMACOLOGY IN ADULTS

DOSAGE AND ADMINISTRATION

CLINICAL PHARMACOLOGY IN PEDIATRIC PATIENTS

ADVERSE REACTIONS

CLINICAL PHARMACOLOGY IN ADULTS

PRECAUTIONS

DOSAGE AND ADMINISTRATION

Body as a Whole:

Cardiovascular:

Gastrointestinal:

Hematologic:

Hypersensitivity:

Musculoskeletal:

Nervous System/Psychiatric:

Respiratory:

Skin:

Special Senses:

Other:

Pediatric Patients

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).